Management of lipoprotein X and its complications in a patient with primary sclerosing cholangitis.

Management of lipoprotein X and its complications in a patient with primary sclerosing cholangitis. Clin Lipidol. 2015 Aug 1;10(4):305-312 Authors: Brandt EJ, Regnier SM, Leung EK, Chou SH, Baron BW, Te HS, Davidson MH, Sargis RM Abstract Lipoprotein X (LpX) is an abnormal lipoprotein found in conditions such as lecithin:cholesterol acyltransferase deficiency and cholestatic states (e.g., primary biliary cirrhosis and primary sclerosing cholangitis). Management of severe hypercholesterolemia due to LpX with drugs and physical removal methods is not well established in the literature. A case is discussed of a 51-year-old woman who presented with multiple electrolyte abnormalities, xanthomas and neuropathy found to be secondary to LpX in the setting of primary sclerosing cholangitis. This case highlights that oral medications, including statins, may be insufficient to normalize lipid levels or improve clinical symptoms of LpX and presents therapeutic plasma exchange as a safe and effective therapeutic option to treat the morbid sequela of LpX hyperlipidemia. PMID: 26413163 [PubMed - as supplied by publisher]
Source: Clinical Lipidology - Category: Lipidology Tags: Clin Lipidol Source Type: research